Cronos CRON
NASDAQ CRON
$3.31 +0.09 (+2.80%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cronos (CRON) Cash from Investing Activities (2019 - 2026)

Cronos (CRON) posted quarterly Cash from Investing Activities of $38.0 million for Q1 2026, up 168.7% year-over-year from $14.2 million in Q1 2025, and up 1266.97% quarter-over-quarter from $2.8 million in Q4 2025.

Cronos (CRON) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Cronos' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $38.0 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 168.7% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $16.8 million (up 124.12% YoY), while the FY2025 annual figure was -$76.6 million, down 143.71% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $38.0 million, up from $2.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $189.6 million in Q1 2024, with the low at -$303.8 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$818000.0 (2024), against an average of $4.4 million.
  • Peak annual rise in Cash from Investing Activities reached 231.33% in 2023, while the deepest fall reached 303912.0% in 2023.
  • Cronos' Cash from Investing Activities stood at $158.5 million in 2022, then tumbled by 48.32% to $81.9 million in 2023, then plunged by 106.14% to -$5.0 million in 2024, then surged by 155.29% to $2.8 million in 2025, then jumped by 1266.97% to $38.0 million in 2026.
  • Business Quant data shows CRON's Cash from Investing Activities at $38.0 million in Q1 2026, $2.8 million in Q4 2025, and -$23.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -491.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Cronos 1.23 Bn 437.76 Mn 28.45 Mn -358.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -358.30 Mn
Jun 30, 2026 -358.30 Mn
Mar 31, 2026 38.03 Mn
Mar 31, 2026 38.03 Mn
Dec 31, 2025 2.78 Mn
Dec 31, 2025 2.78 Mn
Sep 30, 2025 -23.00 Mn
Sep 30, 2025 -23.00 Mn
Jun 30, 2025 -983,000.00
Jun 30, 2025 -983,000.00
Mar 31, 2025 -55.36 Mn
Mar 31, 2025 -55.36 Mn
Dec 31, 2024 -5.03 Mn
Dec 31, 2024 -5.03 Mn
Sep 30, 2024 -818,000.00
Sep 30, 2024 -818,000.00
Jun 30, 2024 -8.56 Mn
Jun 30, 2024 -8.56 Mn
Mar 31, 2024 189.56 Mn
Mar 31, 2024 189.56 Mn